Altria Group Inc. sues FDA as Altria Group Inc. stock costs EUR 59.88
Published on 10/03/2026 at 11:40 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Altria Group Inc. sued the U.S. Food and Drug Administration on September 2, 2026, according to a Reuters report published by U.S. News. In weekend trading at Lang & Schwarz, Altria Group Inc. stock costs EUR 59.88 at 11:36 a.m. CEST on October 3, 2026. That is plus 0.02 percent versus the EUR 59.87 close at Lang & Schwarz on October 2, 2026.
Weekend trading at Lang & Schwarz
The Lang & Schwarz bid is EUR 59.76 and the ask is EUR 60.00. The price remains close to the prior trading-day reference, with the change measured against the October 2, 2026 close at Lang & Schwarz. The further course of weekend trading at Lang & Schwarz until 1:00 p.m. CEST is shown by the continuously updated real-time quote of Altria Group Inc. stock.
The last Xetra trading day
The reference close for the euro price was EUR 59.87 at Lang & Schwarz on October 2, 2026. Xetra is closed during the weekend-trading period.
Altria’s FDA lawsuit
The lawsuit seeks to force the FDA to overhaul its review process for new tobacco products, the Reuters report published by U.S. News said. Altria’s complaint argues that the FDA’s approach has delayed products such as its on! nicotine pouches and conflicts with a legal requirement for decisions within 180 days of an application. The filing was made in federal court in Lubbock, Texas, and included other plaintiffs. The FDA had not immediately responded to a request for comment cited in the report.
Next Xetra session
The next Xetra session is scheduled for October 5, 2026.
